Simultaneous measurement of RBC velocity, flux, hematocrit and shear rate in vascular networks - PubMed (original) (raw)
Simultaneous measurement of RBC velocity, flux, hematocrit and shear rate in vascular networks
Walid S Kamoun et al. Nat Methods. 2010 Aug.
Abstract
Not all tumor vessels are equal. Tumor-associated vasculature includes immature vessels, regressing vessels, transport vessels undergoing arteriogenesis and peritumor vessels influenced by tumor growth factors. Current techniques for analyzing tumor blood flow do not discriminate between vessel subtypes and only measure average changes from a population of dissimilar vessels. We developed methodologies for simultaneously quantifying blood flow (velocity, flux, hematocrit and shear rate) in extended networks at single-capillary resolution in vivo. Our approach relies on deconvolution of signals produced by labeled red blood cells as they move relative to the scanning laser of a confocal or multiphoton microscope and provides fully resolved three-dimensional flow profiles within vessel networks. Using this methodology, we show that blood velocity profiles are asymmetric near intussusceptive tissue structures in tumors in mice. Furthermore, we show that subpopulations of vessels, classified by functional parameters, exist in and around a tumor and in normal brain tissue.
Conflict of interest statement
Authors’ Disclosures of Potential Conflicts of Interest
Rakesh K. Jain has an advisory role in the following companies: SynDevRx, AstraZeneca, Dyax, Millenium and Honoraria role in AstraZeneca
Figures
Figure 1. Description, validation and application of RTLS and RVFS
(a) Representative MPLSM angiogram of a tumor blood vessel. x vs t plots were generated by scanning along the centerline of the vessel with ALS and perpendicular to the vessel with RTLS. Analysis of flow velocity is based on the slope of the RBC signal (Δx/Δt) for ALS and on residence time (rt) for RTLS. RBC velocity and flux measured along the vessel cross-section using RTLS are compared to ALS-based analysis of flow (mean ± s.e.m.). (b) A single vessel scanned with a range of scanning velocities in two opposing scanning directions (scanning velocity - Vs). Scanning from top to bottom with velocities from 1.1 to 1.5 mm s−1 caused "velocity-matched" red blood cells with higher residence times (rt) and a measurable traveled distance (d), which can be used to measure velocity. (DiD, 1,1-dioctadecyl-3,3,3,3-tetramethylindodicarbocyanine perchlorate) (c) 3D MPLSM angiogram of the brain of a tumor-bearing mouse illustrating the position of the line scans performed at several z planes. Comprehensive velocity and flux 3D maps were generated using RTLS (d) 3D Velocity map of a glioma network analyzed by RTLS and RVFS. Vessels in which RVFS velocity measurement differs from RTLS due to low RBC flux (closed arrowheads). Scale bars, 100 µm (a), 50 µm (b), 100 µm (c), 100 µm (d).
Figure 2. Analysis of cross-sectional flow profiles within tumor vessels undergoing intussusceptive angiogenesis
Cross-sectional velocity, flux, hematocrit shear rate profiles and raw data maps upstream and at the level of a single (a) or multiple (b) intussusceptions (yellow arrow heads Scale bars, 50 µm (a), 50 µm (b). Bigger images are scanned areas of the plane where the cross-sectional line scanning was done.
Figure 3. Multiparametric phenotipic vessel clustering to compare vessels within tumor, peritumor and contralateral brain regions in a glioma model
(a) All the vessels analyzed in U87-bearing animals (n = 6) are plotted. Scatter plots of velocity vs flux and diameter vs hematocrit showing the gating applied to analyze three different vessel sub-types (hypoperfused, transport, and hemodiluted).(b) Box plots for vessel diameter from clustered vessels. (* P < 0.05). (c). U87 MPLSM micrographs. Rhodamine BSA was used for the angiographic contrast and fluorescent RBCs (green) were injected 1 day prior to imaging. Glioma cells expressed GFP which allowed accurate localization of the tumor and determination of the tumor edge (light blue dashed line). Tumor vessels are heterogeneous with high (closed arrow head) and low (open arrow head) hematocrit vessels. Peritumor vessels are morphologically normal and have low (open arrow head) hematocrit when compared to contralateral brain. Scale bars, 100 µm (c).
Similar articles
- Hemodynamic parameters in blood vessels in choroidal melanoma xenografts and rat choroid.
Braun RD, Abbas A, Bukhari SO, Wilson W 3rd. Braun RD, et al. Invest Ophthalmol Vis Sci. 2002 Sep;43(9):3045-52. Invest Ophthalmol Vis Sci. 2002. PMID: 12202528 Free PMC article. - The effect of hematocrit and leukocyte adherence on flow direction in the microcirculation.
King MR, Bansal D, Kim MB, Sarelius IH. King MR, et al. Ann Biomed Eng. 2004 Jun;32(6):803-14. doi: 10.1023/b:abme.0000030256.37022.02. Ann Biomed Eng. 2004. PMID: 15255211 - In vivo two-photon excited fluorescence microscopy reveals cardiac- and respiration-dependent pulsatile blood flow in cortical blood vessels in mice.
Santisakultarm TP, Cornelius NR, Nishimura N, Schafer AI, Silver RT, Doerschuk PC, Olbricht WL, Schaffer CB. Santisakultarm TP, et al. Am J Physiol Heart Circ Physiol. 2012 Apr 1;302(7):H1367-77. doi: 10.1152/ajpheart.00417.2011. Epub 2012 Jan 20. Am J Physiol Heart Circ Physiol. 2012. PMID: 22268102 Free PMC article. - Determinants of tumor blood flow: a review.
Jain RK. Jain RK. Cancer Res. 1988 May 15;48(10):2641-58. Cancer Res. 1988. PMID: 3282647 Review. - Distribution of flow and red cell flux in the microcirculation.
Gaehtgens P. Gaehtgens P. Scand J Clin Lab Invest Suppl. 1981;156:83-7. doi: 10.3109/00365518109097437. Scand J Clin Lab Invest Suppl. 1981. PMID: 7034151 Review.
Cited by
- Quantifying uncertainties in the microvascular transport of nanoparticles.
Lee TR, Greene MS, Jiang Z, Kopacz AM, Decuzzi P, Chen W, Liu WK. Lee TR, et al. Biomech Model Mechanobiol. 2014 Jun;13(3):515-26. doi: 10.1007/s10237-013-0513-0. Epub 2013 Jul 20. Biomech Model Mechanobiol. 2014. PMID: 23872851 Free PMC article. - Line-scanning particle image velocimetry: an optical approach for quantifying a wide range of blood flow speeds in live animals.
Kim TN, Goodwill PW, Chen Y, Conolly SM, Schaffer CB, Liepmann D, Wang RA. Kim TN, et al. PLoS One. 2012;7(6):e38590. doi: 10.1371/journal.pone.0038590. Epub 2012 Jun 26. PLoS One. 2012. PMID: 22761686 Free PMC article. - Intravital imaging-based analysis tools for vessel identification and assessment of concurrent dynamic vascular events.
Honkura N, Richards M, Laviña B, Sáinz-Jaspeado M, Betsholtz C, Claesson-Welsh L. Honkura N, et al. Nat Commun. 2018 Jul 16;9(1):2746. doi: 10.1038/s41467-018-04929-8. Nat Commun. 2018. PMID: 30013228 Free PMC article. - Delivering nanomedicine to solid tumors.
Jain RK, Stylianopoulos T. Jain RK, et al. Nat Rev Clin Oncol. 2010 Nov;7(11):653-64. doi: 10.1038/nrclinonc.2010.139. Epub 2010 Sep 14. Nat Rev Clin Oncol. 2010. PMID: 20838415 Free PMC article. Review. - Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases.
Carmeliet P, Jain RK. Carmeliet P, et al. Nat Rev Drug Discov. 2011 Jun;10(6):417-27. doi: 10.1038/nrd3455. Nat Rev Drug Discov. 2011. PMID: 21629292 Review.
References
- Brizel DM, et al. A comparison of tumor and normal tissue microvascular hematocrits and red cell fluxes in a rat window chamber model. Int J Radiat Oncol Biol Phys. 1993;25:269–276. - PubMed
- Endrich B, Reinhold HS, Gross JF, Intaglietta M. Tissue perfusion inhomogeneity during early tumor growth in rats. J Natl Cancer Inst. 1979;62:387–395. - PubMed
- Kamoun WS, Schmugge SJ, Kraftchick JP, Clemens MG, Shin MC. Liver microcirculation analysis by red blood cell motion modeling in intravital microscopy images. IEEE Trans Biomed Eng. 2008;55:162–170. - PubMed
Publication types
MeSH terms
Grants and funding
- T32 CA073479/CA/NCI NIH HHS/United States
- T32 CA073479-11/CA/NCI NIH HHS/United States
- P01 CA080124-09/CA/NCI NIH HHS/United States
- R01 CA126642-03/CA/NCI NIH HHS/United States
- R01 CA115767-04/CA/NCI NIH HHS/United States
- R01 CA085140/CA/NCI NIH HHS/United States
- T32 CA073479-12/CA/NCI NIH HHS/United States
- P01 CA080124/CA/NCI NIH HHS/United States
- R01 HL064240/HL/NHLBI NIH HHS/United States
- R01 CA115767/CA/NCI NIH HHS/United States
- P01 CA080124-08/CA/NCI NIH HHS/United States
- R01 CA115767-02/CA/NCI NIH HHS/United States
- R01 CA126642/CA/NCI NIH HHS/United States
- R01 CA085140-10/CA/NCI NIH HHS/United States
- R01 CA085140-07/CA/NCI NIH HHS/United States
- R01 CA149285/CA/NCI NIH HHS/United States
- R01 CA115767-03/CA/NCI NIH HHS/United States
- P01CA80124/CA/NCI NIH HHS/United States
- P01 CA080124-10/CA/NCI NIH HHS/United States
- R01CA149285/CA/NCI NIH HHS/United States
- R01 CA115767-05/CA/NCI NIH HHS/United States
- T32 CA073479-13/CA/NCI NIH HHS/United States
- P01 CA080124-100006/CA/NCI NIH HHS/United States
- R01 CA126642-02/CA/NCI NIH HHS/United States
- R01 CA085140-06/CA/NCI NIH HHS/United States
- R01 HL064240-08/HL/NHLBI NIH HHS/United States
- R01 CA115767-01A1/CA/NCI NIH HHS/United States
- R01 CA149285-02/CA/NCI NIH HHS/United States
- R01 CA085140-09/CA/NCI NIH HHS/United States
- R01HL064240/HL/NHLBI NIH HHS/United States
- R01 CA126642-02S1/CA/NCI NIH HHS/United States
- R01 CA126642-01A1/CA/NCI NIH HHS/United States
- P01 CA080124-07/CA/NCI NIH HHS/United States
- T32 CA073479-09/CA/NCI NIH HHS/United States
- T32 CA073479-10/CA/NCI NIH HHS/United States
- P01 CA080124-06A2/CA/NCI NIH HHS/United States
- R01 CA096915/CA/NCI NIH HHS/United States
- P01 CA080124-109001/CA/NCI NIH HHS/United States
- R01 CA085140-08/CA/NCI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources